Visa — The credit card issuer missed estimates by one cent with quarterly profit of 62 cents per share, though revenue was slightly above forecasts. Visa also authorized a new $5 billion share repurchase program, and also announced it was buying Visa Europe for about $18.2 billion.
Dyax Corp. — The drug developer is being bought by Britain's Shire for $5.9 billion or $37.30 per share in cash.
General Electric — GE said it has completed the acquisition of the power and grid businesses from France's Alstom.
Clorox — The household products maker earned an adjusted $1.32 per share for its latest quarter, with revenue also beating analyst projections. Clorox saw sales increases in both domestic and international markets, and said its US market share gain was its biggest in three years.
Estee Lauder — Estee Lauder reported quarterly profit of 82 cents per share, beating estimates by 12 cents, and revenue was also above estimates. The company's results were helped by sales increases across a variety of categories and geographic regions, despite the negative impact of a stronger dollar. The personal care products maker also increased its quarterly dividend by 25 percent to 30 cents per share.
Coty — The personal care products maker is buying the beauty business of Brazil's Hypermarcas for $1 billion in cash.
Constant Contact — The maker of digital market tools is being bought by online technology company Endurance International Group for $1.1 billion in cash or $32 per share. Constant Contact had closed Friday at $26.10 per share.
TreeHouse Foods — TreeHouse is buying the private brands business of ConAgra (CAG) for $2.7 billion. The two sides had been reported to be in late-stage talks on October 22.
Towers Watson — The consulting firm reported adjusted quarterly profit of $1.49 per share, 15 cents above estimates, and revenue beat Street forecasts as well.
Valeant Pharmaceuticals — S&P downgraded the drug maker's rating one notch to B+ from BB-, noting the potential harm to its reputation from the controversy over its relationship with specialty pharmacy Philidor.
Vertex Pharmaceuticals — Vertex received a Justice Department subpoena, seeking documents related to practices at one of its bioanalytical labs. Vertex said it is in the process of responding to the subpoena.
PMC-Sierra — The chipmaker said the latest takeover bid from Microsemi is not superior to the most recent bid from Skyworks Solutions and that it is committed to completing its deal with Skyworks.
HSBC — HSBC reported a better than expected third quarter profit of $6.1 billion, as a drop in regulatory fines more than made up for increased spending on compliance and a slowdown in the bank's Asian markets.
Chipotle Mexican Grill — Chipotle shut down its stores in Seattle and Portland after a reported outbreak of E. coli bacteria. The move comes in what the restaurant chain calls "an abundance of caution" after it was notified of about 20 cases from customers who ate at six restaurants in those cities.
Sprint — Sprit seeks to cut spending in fiscal 2016 by as much as $2.5 billion. The wireless carrier plans to accomplish those cuts through cost controls and a number of layoffs.
Sears Holdings — The retailer's Kmart unit is bringing back its iconic "Bluelight Special," in an attempt to boost flagging sales at the retailer.
Boeing — Boeing will likely match an announced production increase of single-aisle aircraft by rival Airbus, according to Reuters. Airbus plans to increase production by 20 percent to 60 per month.
EMC — The data storage company and merger partner Dell are considering an early 2016 IPO for Pivotal, EMC's joint venture with General Electric. Re/code reports that EMC and Dell are considering offering a minority stake to the public, just as EMC as done with VMWare in the past.
HP Inc., Hewlett Packard Enterprise — HP Inc. and Hewlett-Packard Enterprise will begin trading as separate companies today, following the split of Hewlett-Packard into two.
Amazon.com — Amazon is shutting down its Amazon Local daily deals unit as well as its mobile credit-card processing division.
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
Disclaimer:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.